AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 13.23 USD 4.34% Market Closed
Market Cap: 545.1m USD

AngioDynamics Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

AngioDynamics Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
AngioDynamics Inc
NASDAQ:ANGO
Revenue
$300.7m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
-2%
Becton Dickinson and Co
NYSE:BDX
Revenue
$21.8B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Revenue
$19.4B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Revenue
$24.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$43.8B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$9.6B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
15%
No Stocks Found

AngioDynamics Inc
Glance View

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

ANGO Intrinsic Value
10.3 USD
Overvaluation 22%
Intrinsic Value
Price

See Also

What is AngioDynamics Inc's Revenue?
Revenue
300.7m USD

Based on the financial report for Aug 31, 2025, AngioDynamics Inc's Revenue amounts to 300.7m USD.

What is AngioDynamics Inc's Revenue growth rate?
Revenue CAGR 10Y
-2%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for AngioDynamics Inc have been -2% over the past three years , 2% over the past five years , and -2% over the past ten years .

Back to Top